Cargando…

EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs

Detalles Bibliográficos
Autor principal:	Bijlsma, Johannes WJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958080/ https://www.ncbi.nlm.nih.gov/pubmed/33563595 http://dx.doi.org/10.1136/annrheumdis-2020-219773

Ejemplares similares

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Wieczorek, Maud, et al.
Publicado: (2022)

SARS-CoV-2 vaccine development, access, and equity
por: Kim, Jerome H.
Publicado: (2020)

A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development
por: Jatoi, Isak, et al.
Publicado: (2021)

Viewpoint: vaccine inequity in the spotlight
por: Bittaye, Mustapha, et al.
Publicado: (2022)

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations
por: Kedra, Joanna, et al.
Publicado: (2019)

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
por: Oliu-Barton, Miquel, et al.
Publicado: (2022)

SARS-CoV-2 spread in different biosocial strata in Russia in 2020: Groups of risk and victimised groups
por: Sharov, Konstantin S
Publicado: (2021)

SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health
por: Sarkar, Mohammad Abdullah, et al.
Publicado: (2021)

COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache
por: Martelletti, Paolo
Publicado: (2023)

Estimating the impact of vaccination on reducing COVID-19 burden in the United States: December 2020 to March 2022
por: Sah, Pratha, et al.
Publicado: (2022)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2022)

SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021)

Marketing SARS-CoV-2 Vaccines: an Opportunity to Test a Nobel Prize–Winning Theory
por: Verma, Amol A., et al.
Publicado: (2021)

Epidemiological profiles of SARS-CoV and SARS-Cov-2 in Singapore and its promising containment strategies
por: Chaturvedi, Rini, et al.
Publicado: (2021)

Human-Animal Interaction and the Emergence of SARS-CoV-2
por: Hassani, Asma, et al.
Publicado: (2020)

Schrödinger’s Worker: Are They Positive or Negative for SARS-CoV-2?
por: Meloni, Federico, et al.
Publicado: (2020)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2022)

Can Robots Improve Testing Capacity for SARS-CoV-2?
por: Cresswell, Kathrin, et al.
Publicado: (2020)

Reducing Aerosol Transmission of SARS-CoV-2 in Craniomaxillofacial Osteosynthesis
por: Arakeri, Gururaj, et al.
Publicado: (2020)

In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease
por: Epelbaum, Oleg, et al.
Publicado: (2020)

Targeting neuropilins as a viable SARS‐CoV‐2 treatment
por: Sarabipour, Sarvenaz, et al.
Publicado: (2021)

Global variation in sequencing impedes SARS-CoV-2 surveillance
por: Crawford, Dana C., et al.
Publicado: (2021)

Recommendations for return to sport during the SARS-CoV-2 pandemic
por: Löllgen, Herbert, et al.
Publicado: (2020)

Adjusting to the Reign of Webinars: Viewpoint
por: Karabacak, Mert, et al.
Publicado: (2021)

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020)

Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection
por: Thapa, Bibechan
Publicado: (2021)

A focus on the spread of the delta variant of SARS-CoV-2 in India
por: Novelli, Giuseppe, et al.
Publicado: (2021)

Could the Biogeographic Background Affect the Emergence of SARS-CoV-2 Variants?
por: Akaishi, Tetsuya
Publicado: (2022)

Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection
por: Banu, Sarena, et al.
Publicado: (2022)

SARS-CoV-2 in Malawi: Are we sacrificing the Youth in sub-Saharan Africa?
por: Nandi, Biplap, et al.
Publicado: (2020)

Contact lens use at the time of SARS-CoV-2 pandemic for healthcare workers
por: Bhargava, Raghav
Publicado: (2020)

Hospital preparedness for mass critical care during SARS-CoV-2 pandemic
por: Wurmb, Thomas, et al.
Publicado: (2020)

SARS-CoV-2 and COVID-19: revisiting the most important research questions
por: Yuen, Kit-San, et al.
Publicado: (2021)

Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics
por: Coryell, Michael P., et al.
Publicado: (2022)

Considering innate immune responses in SARS-CoV-2 infection and COVID-19
por: Diamond, Michael S., et al.
Publicado: (2022)

Partner Notification: A Community Viewpoint
por: Ayala, George, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9813d87hhlat1095gns8h0ucck